ITEM 3. SUMMARY OF EUFMD ACTIVITIES CONDUCTED SINCE OCTOBER 2012

term value of certain antigens, so that recent results should be seen in perspective. The Secretary proposed that a column be added to the recommendations table, which was agreed. The extent of variation in West Eurasia compared to South America was also raised; KS replied that past reports indicated similar levels of antigen variation in South America1 and the extent of variation may linked to the extent of circulation and natural immunity, since high and effective vaccination coverage in South America seemed to coincide with reduced antigenic variation. The WRL Vaccine Recommendations (below) remain unchanged from those given in April 2012:

Vaccine Recommendations (National & European Antigen Banks)

HIGH PRIORITY

MEDIUM PRIORITY

LOW PRIORITY

O Manisa* O PanAsia -2* O BFS or Campos A-Iran-05 A24 Cruzeiro A22 Iraq Asia 1 Shamir* SAT 2 Saudi Arabia (or equivalent - SAT 2 Eritrea) A Argentina 01 A Iran 96 A Iran 99 A Eritrea A Iran 87 or A Saudi Arabia 23/86 (or equivalent) A Malaysia 97 (or Thai equivalent such as A/Sak/97)* O Taiwan 97 (pig-adapted strain or Philippine equivalent)* SAT 1 South Africa SAT 2 Zimbabwe A15 Bangkok related strain A Kenya A87 Argentina related strain SAT 1 Kenya SAT 2 Kenya SAT 3 Zimbabwe C Noville

Within category: not in order of importance

* or additional strain

Conclusions

1. The current situation with SAT2 in Egypt and Libya remains unclear following the epidemics in 2012; since the EuFMD/FAO support to surveillance in Egypt stopped in October 2012, samples and information have not been provided for analysis. It cannot be concluded that circulation has ceased. 2. The absence of confirmed recent Asia-1 outbreaks in Turkey and Iran suggests that the epidemic that started in early 2011 may be over (Appendix 2: December report of EuFMD). Recent increase in type A outbreaks in Turkey are the new concern. 3. The WRL contributes the majority of virus typing information reported through the OIE/FAO reference Centres network, but there remains critical gaps in virus typing in some pools, particularly in Africa. More work is needed to ensure that the regional laboratory networks are supported to undertaken virus typing at national or regional level and submit samples for advanced analysis to international RCs.

Two reports were provided, one being a brief report (“leaflet”) for distribution on the overall programme in the past year, showing how activities relate to the proposed “3 Pillars” of the new Strategic Plan (Appendix 4), and the second (Appendix 5) being the 6 month “Narrative report” on

1 Fernandez et al, Develop.biol Standard vol 35, pp231-235. Gives details on 6 type A subtypes of significance arising in a 8 year period which did or did not persist in the field.